David Heisler

Dr. David Heisler

University of Texas Southwestern Medical Center
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2021 in Cell
Verified
Journal Article
Closed access
JHJustin M. Hansen
Justin M. Hansen
MJMaarten F. de Jong
Maarten F. de Jong
QWQi Wu
Qi Wu
LZLi-Shu Zhang
Li-Shu Zhang
David HeislerDavid Heisler
David Heisler
NANeal M. Alto
Neal M. Alto

31 July 2015 in Science
Verified
Journal Article
Closed access
PDF file
David HeislerDavid Heisler
David Heisler
EKElena Kudryashova
Elena Kudryashova
DGDmitry O. Grinevich
Dmitry O. Grinevich
CSCristian Suarez
Cristian Suarez
JWJonathan D. Winkelman
Jonathan D. Winkelman
DKDmitri Kudryashov
Dmitri Kudryashov
A little toxin can do a lot: The actin cross-linking domain (ACD) is an actin-specific toxin produced by several bacterial pathogens. Heisler et al. discovered that ACD's pathogenic mechanism involves a highly unusual toxicity amplification cascade. Rather than directly inactivating the actin cytoskeleton, ACD blocks the activity of formins, actin regulatory proteins that play crucial roles in numerous cellular activities. ACD is exceptionally potent, even though its substrate is the most abundant protein of a eukaryotic cell: actin. Science , this issue p. 535

25 January 2023 in eLife
Verified
Journal Article
Open access
David HeislerDavid Heisler
David Heisler
KJKristen A Johnson
Kristen A Johnson
DMDuo H Ma
Duo H Ma
MOMaikke B Ohlson
Maikke B Ohlson
LZLishu Zhang
Lishu Zhang
ARArun Radhakrishnan
Arun Radhakrishnan
Most of the cholesterol in the plasma membranes (PMs) of animal cells is sequestered through interactions with phospholipids and transmembrane domains of proteins. However, as cholesterol concentration rises above the PM’s sequestration capacity, a new pool of cholesterol, called accessible cholesterol, emerges. The transport of accessible cholesterol between the PM and the endoplasmic reticulum (ER) is critical to maintain cholesterol homeostasis. This pathway has also been implicated in the suppression of both bacterial and viral pathogens by immunomodulatory oxysterols. Here, we describe a mechanism of depletion of accessible cholesterol from PMs by the oxysterol 25-hydroxycholesterol (25HC). We show that 25HC-mediated activation of acyl coenzyme A: cholesterol acyltransferase (ACAT) in the ER creates an imbalance in the equilibrium distribution of accessible cholesterol between the ER and PM. This imbalance triggers the rapid internalization of accessible cholesterol from the PM, and this depletion is sustained for long periods of time through 25HC-mediated suppression of SREBPs and continued activation of ACAT. In support of a physiological role for this mechanism, 25HC failed to suppress Zika virus and human coronavirus infection in ACAT-deficient cells, and Listeria monocytogenes infection in ACAT-deficient cells and mice. We propose that selective depletion of accessible PM cholesterol triggered by ACAT activation and sustained through SREBP suppression underpins the immunological activities of 25HC and a functionally related class of oxysterols.

2 May 2014 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
EKElena Kudryashova
Elena Kudryashova
David HeislerDavid Heisler
David Heisler
AZAndrew Zywiec
Andrew Zywiec
DKDmitri Kudryashov
Dmitri Kudryashov

1 May 2018 in Current Biology
Verified
Journal Article
Closed access
EKElena Kudryashova
Elena Kudryashova
David HeislerDavid Heisler
David Heisler
BWBlake Williams
Blake Williams
AHAlyssa J. Harker
Alyssa J. Harker
KSKyle Shafer
Kyle Shafer
DKDmitri Kudryashov
Dmitri Kudryashov

24 August 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
VPvedud Purde
vedud Purde
EKElena Kudryashova
Elena Kudryashova
David HeislerDavid Heisler
David Heisler
RSReena Shakya
Reena Shakya
DKDmitri Kudryashov
Dmitri Kudryashov
Significance: Protein reconstitution via transsplicing by split inteins is an indispensable tool in protein engineering, biotechnology, and experimental therapeutics. In living cells, the application of split inteins has been limited to their nonspecific delivery or expression from genetic elements, which come with substantial limitations in specificity of targeting and temporal control of expression and generation of the transspliced product. To overcome these limitations we designed a protocol for delivering the split-intein protein fragments to the cell cytoplasm via a receptor-specific toxin-based delivery machinery. We achieved a precisely controlled reconstitution of a functional catalytic domain of diphtheria toxin from its two dysfunctional fragments, one expressed and one delivered as a protein, in selective subpopulations of cells in mixed cultures and in vivo.